Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Ribero

Showing results (61-70 of 266) with videos related to

Pageof 27
Sort By:
International Journal of STD & AIDS|October 11, 2021
Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patientMichele Parietti, Mattia Trunfio, Sergio Delmonte, et al.
Acta Dermato-Venereologica|September 6, 2022
Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern ItalyLuca Mastorino, Paolo Dapavo, Mattia Trunfio, et al.
Dermatologic Therapy|October 10, 2022
Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasisGiuseppe Gallo, Luca Mastorino, Diego Barilà, et al.
Igiene E Sanita Pubblica|December 17, 2009
[Quality evaluation of informed consent forms: a pilot study]Marco Bo, Umberto Fiandra, Ida Marina Raciti, et al.
Frontiers in Medicine|February 27, 2023
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancerMarco Rubatto, Nadia Sciamarrelli, Silvia Borriello, et al.
Frontiers in Psychology|March 2, 2026
From skin clearance to psychological wellbeing: real-world outcomes of biologic therapy in psoriasisFrancesco Cuniberti, Marco Miniotti, Mariagiulia Bailon, et al.
Experimental Dermatology|February 17, 2025
Dose Modulation Strategies in Psoriatic Patients: Real-Life Pilot Comparison Between Risankizumab and Guselkumab up to 12 Months After Dose SpacingLuca Mastorino, Paolo Dapavo, Michela Ortoncelli, et al.
Journal of Clinical Medicine|August 27, 2021
Familial Melanoma and Susceptibility Genes: A Review of the Most Common Clinical and Dermoscopic Phenotypic Aspect, Associated Malignancies and Practical Tips for ManagementLamberto Zocchi, Alberto Lontano, Martina Merli, et al.
Journal of Clinical Medicine|August 14, 2025
The Epidemiology of Syphilis Worldwide in the Last DecadeFrancois Rosset, Valentina Celoria, Sergio Delmonte, et al.
Dermatologic Therapy|June 28, 2022
Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real-life studyLuca Mastorino, Niccolò Siliquini, Gianluca Avallone, et al.
Pageof 27

Showing results (61-70 of 266) with videos related to

Sort By:
Pageof 27
International Journal of STD & AIDS|October 11, 2021
Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patientMichele Parietti, Mattia Trunfio, Sergio Delmonte, et al.
Acta Dermato-Venereologica|September 6, 2022
Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern ItalyLuca Mastorino, Paolo Dapavo, Mattia Trunfio, et al.
Dermatologic Therapy|October 10, 2022
Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasisGiuseppe Gallo, Luca Mastorino, Diego Barilà, et al.
Igiene E Sanita Pubblica|December 17, 2009
[Quality evaluation of informed consent forms: a pilot study]Marco Bo, Umberto Fiandra, Ida Marina Raciti, et al.
Frontiers in Medicine|February 27, 2023
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancerMarco Rubatto, Nadia Sciamarrelli, Silvia Borriello, et al.
Frontiers in Psychology|March 2, 2026
From skin clearance to psychological wellbeing: real-world outcomes of biologic therapy in psoriasisFrancesco Cuniberti, Marco Miniotti, Mariagiulia Bailon, et al.
Experimental Dermatology|February 17, 2025
Dose Modulation Strategies in Psoriatic Patients: Real-Life Pilot Comparison Between Risankizumab and Guselkumab up to 12 Months After Dose SpacingLuca Mastorino, Paolo Dapavo, Michela Ortoncelli, et al.
Journal of Clinical Medicine|August 27, 2021
Familial Melanoma and Susceptibility Genes: A Review of the Most Common Clinical and Dermoscopic Phenotypic Aspect, Associated Malignancies and Practical Tips for ManagementLamberto Zocchi, Alberto Lontano, Martina Merli, et al.
Journal of Clinical Medicine|August 14, 2025
The Epidemiology of Syphilis Worldwide in the Last DecadeFrancois Rosset, Valentina Celoria, Sergio Delmonte, et al.
Dermatologic Therapy|June 28, 2022
Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real-life studyLuca Mastorino, Niccolò Siliquini, Gianluca Avallone, et al.
Pageof 27